Abstract:Cardiovascular diseases lead to stiffening of blood vessels. We identified a population of smooth muscle-derived progenitor cells that reside in the adventitial layer (AdvSca1-SM cells) that drive vascular fibrosis after acute vascular injury. AdvSca1-SM cells can differentiate into myofibroblasts and secrete pro-remodeling factors including extracellular matrix proteins and pro-inflammatory cytokines. While the response of AdvSca1-SM cells to vascular injury has been studied, the epigenetic changes that influence their differentiation towards myofibroblasts is poorly understood. We observed Brahma-related gene 1 (Brg1), a highly conserved chromatin remodeling ATPase, is upregulated in AdvSca1-SM cells in response to vascular injury and may be a key factor in regulating gene expression to influence AdvSca1-SM differentiation. We hypothesize that Brg1 induces expression of gene sets associated with remodeling and fibrosis and ultimately drives AdvSca1-SM cell differentiation towards pathologic myofibroblasts. Results: Carotid arteries from mice subject to carotid ligation exhibit decreased perivascular collagen deposition, smaller neointima, decreased adventitial expansion, decreased numbers of alpha-actin positive AdvSca1-SM cells, and fewer infiltrating macrophages when treated with the pharmacological Brg1 bromodomain inhibitor PFI-3 as compared to mice that received vehicle control. In a cell culture system, TGF-β induces AdvSca1-SM cells to express myofibroblast-specific genes, including alpha actin and periostin, and demonstrate enhanced contractile function in collagen contraction assays. PFI-3 blocks TGF-β induced myofibroblast gene expression and dampens contractile function. Mechanistically, CUT&RUN assays reveal that TGF-β leads to recruitment of Brg1 to the promoters of fibrosis-related genes, and this recruitment is blocked by PFI-3. This suggests that TGF-β induces Brg1 to remodel chromatin and drive differentiation towards myofibroblasts. These findings suggest Brg1 is a major regulator of vascular remodeling and may be a targetable protein to help people who suffer from disease-related vascular stiffening.

Abstract 651: The Chromatin Remodeler Brg1 Drives Adventitial Progenitor Cell Myofibroblast Differentiation And Vascular Fibrosis